Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of S-555739 in Patients with Seasonal Allergic Rhinitis
jRCT2080221324Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of asapiprant in seasonal allergic rhinitis (SAR), sponsored by Shionogi & Co., Ltd.
02
Drugs
asapiprant
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on jRCT2080221324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221324.